CDRE β€” CADRE HLDGS INC

Ownership history in Qube Research & Technologies Ltd  Β·  9 quarters on record

This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in CADRE HLDGS INC (CDRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2025 Q2)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2023 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
9

Position Intelligence

Qube Research & Technologies Ltd Γ— CDRE AI Analytics

πŸ“‰ Qube Research & Technologies Ltd underperformed the S&P 500 by –11.9% annually on this CDRE position. Timing score: 57% (4/7 decisions correct). Average cost basis: $33.44. Maximum drawdown during holding period: –21.6%.

πŸ“ˆ Position Alpha vs SPY
-11.9%
annualised excess return

❌ Significantly underperformed the S&P 500 by 11.9% ann.
7 quarters analyzed

⏱️ Timing Score
57%

βœ… Decent timing β€” more right than wrong on entries and exits.
4 of 7 add/trim decisions correct

πŸ’° Entry Quality
$33.44
+8.7% vs current ($36.34)

Best entry: $29.29 (2025 Q1)  Β·  Worst: $37.36 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–21.6%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

6 adds Β· 3 trims. Bought during 1 of 3 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    CDRE price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 25,515 -131,437 -83.7% 0.00% $932K $36.34
2025 Q2 ADDED 156,952 +128,823 +458.0% 0.01% $5.0M $31.61
2025 Q1 ADDED 28,129 +2,943 +11.7% 0.00% $833K $29.29
2024 Q4 REDUCED 25,186 -46,086 -64.7% 0.00% $814K $31.88
2024 Q3 ADDED 71,272 +56,885 +395.4% 0.00% $2.7M $37.36
2024 Q2 REDUCED 14,387 -72,814 -83.5% 0.00% $483K $32.95
2024 Q1 ADDED 87,201 +41,963 +92.8% 0.01% $3.2M $35.45
2023 Q4 ADDED 45,238 +45,120 +38237.3% 0.00% $1.5M $32.13
2023 Q3 INITIATED 118 β€” β€” 0.00% $3K β€”

🏒 Other funds also holding CDRE

As of 2025 Q4 β€” sorted by position size

WYNNEFIELD CAPITAL INC 3Y 7Y 23.19% Catawba River Capital 3Y 8.35% Greenhouse Funds LLLP 3Y 7Y 4.12% REINHART PARTNERS, LLC. 3Y 7Y 2.65% Advantage Alpha Capital Partners LP 3Y 1.15% Pembroke Management, LTD 3Y 7Y 0.67% CORBYN INVESTMENT MANAGEMENT INC/MD 3Y 7Y 0.58% Old West Investment Management, LLC 3Y 7Y 0.54% nVerses Capital, LLC 0.48% PHILADELPHIA TRUST CO 3Y 7Y 0.46%
← Back to Qube Research & Technologies Ltd Holdings